Floyd Robert Michael Insider Trades

Insider Trading History

Track insider trading activity for Floyd Robert Michael. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $230k 82,267 shares
Last Trade
Feb 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4M 10,000 shares
$400.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $1.23M 440,328 shares
Last Trade
Jan 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.7M 95,797 shares
$550.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $965k 344,531 shares
Last Trade
Dec 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.97M 10,851 shares
$550.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $202k 72,267 shares
Last Trade
Oct 06, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.69M 4,163 shares
$1,127.50
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $214k 76,430 shares
Last Trade
Oct 06, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.1M 12,500 shares
$1,127.50
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $934k 333,680 shares
Last Trade
Sep 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.3M 10,850 shares
$1,130.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $179k 63,930 shares
Last Trade
Aug 16, 2022 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$11M 7,000 shares
$1,565.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $904k 322,830 shares
Last Trade
Jun 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.2M 20,064 shares
$1,405.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $848k 302,766 shares
Last Trade
Apr 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$384M 247,841 shares
$1,550.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $199k 70,930 shares
Last Trade
Mar 31, 2022 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$10.5M 7,000 shares
$1,505.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $106k 37,781 shares
Last Trade
Mar 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.1M 10,715 shares
$1,505.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $63.8k 22,780 shares
Last Trade
Dec 31, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.5M 6,722 shares
$2,450.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $18.8k 6,722 shares
Last Trade
Dec 31, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.5M 6,722 shares
$2,450.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $75.8k 27,066 shares
Last Trade
Nov 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.1M 4,286 shares
$3,525.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $26.3k 9,387 shares
Last Trade
Oct 06, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$18.2M 4,663 shares
$3,905.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $40.6k 14,500 shares
Last Trade
Oct 06, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$48.8M 12,500 shares
$3,905.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $45k 16,058 shares
Last Trade
Sep 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.8M 6,024 shares
$4,285.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $16.9k 6,024 shares
Last Trade
Sep 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.8M 6,024 shares
$4,285.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $36k 12,858 shares
Last Trade
Jul 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.3M 23,337 shares
$3,825.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Operating Officer
Holding Value $78.4k 28,000 shares
Last Trade
Jun 22, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.22M 2,000 shares
$3,610.00
$2.80

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up